Laura Lynne Stockton

Array ( [id] => 7533222 [patent_doc_number] => RE042890 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2011-11-01 [patent_title] => 'Furazanobenzimidazoles' [patent_app_type] => reissue [patent_app_number] => 12/796135 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21927 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/042/RE042890.pdf [firstpage_image] =>[orig_patent_app_number] => 12796135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5000427 [patent_doc_number] => 20070043061 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-22 [patent_title] => 'Furazanobenzimidazoles' [patent_app_type] => utility [patent_app_number] => 10/557539 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21871 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20070043061.pdf [firstpage_image] =>[orig_patent_app_number] => 10557539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 83810 [patent_doc_number] => 07741341 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-22 [patent_title] => 'Benzimidazole-derivatives as factor Xa inhibitors' [patent_app_type] => utility [patent_app_number] => 10/849436 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61491 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/741/07741341.pdf [firstpage_image] =>[orig_patent_app_number] => 10849436 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7217043 [patent_doc_number] => 20050054697 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Gyrase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/848474 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18715 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054697.pdf [firstpage_image] =>[orig_patent_app_number] => 10848474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051991 [patent_doc_number] => 20070032536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Compounds, compositions and methods' [patent_app_type] => utility [patent_app_number] => 10/553990 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22372 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032536.pdf [firstpage_image] =>[orig_patent_app_number] => 10553990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432190 [patent_doc_number] => 20040209794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Production of 5-methyl-N-aryl-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds' [patent_app_type] => new [patent_app_number] => 10/844801 [patent_app_country] => US [patent_app_date] => 2004-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6768 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20040209794.pdf [firstpage_image] =>[orig_patent_app_number] => 10844801 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7265130 [patent_doc_number] => 20040242666 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders' [patent_app_type] => new [patent_app_number] => 10/843939 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14130 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20040242666.pdf [firstpage_image] =>[orig_patent_app_number] => 10843939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6972357 [patent_doc_number] => 20050038067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Asymmetric benzimidazoles and related compounds as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 10/845287 [patent_app_country] => US [patent_app_date] => 2004-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12837 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20050038067.pdf [firstpage_image] =>[orig_patent_app_number] => 10845287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623713 [patent_doc_number] => 07138421 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Anti-androgenic pyrrolidines with tumor-inhibiting action' [patent_app_type] => utility [patent_app_number] => 10/841825 [patent_app_country] => US [patent_app_date] => 2004-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17937 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138421.pdf [firstpage_image] =>[orig_patent_app_number] => 10841825 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467023 [patent_doc_number] => 20040198791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Fused imidazole derivative' [patent_app_type] => new [patent_app_number] => 10/479657 [patent_app_country] => US [patent_app_date] => 2004-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9318 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198791.pdf [firstpage_image] =>[orig_patent_app_number] => 10479657 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7318811 [patent_doc_number] => 20040224875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Inhibitors of glutaminyl cyclase' [patent_app_type] => new [patent_app_number] => 10/838993 [patent_app_country] => US [patent_app_date] => 2004-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17979 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224875.pdf [firstpage_image] =>[orig_patent_app_number] => 10838993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276475 [patent_doc_number] => 20040235926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Cannabinoid receptor ligands and uses thereof' [patent_app_type] => new [patent_app_number] => 10/838008 [patent_app_country] => US [patent_app_date] => 2004-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38510 [patent_no_of_claims] => 91 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235926.pdf [firstpage_image] =>[orig_patent_app_number] => 10838008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5754719 [patent_doc_number] => 20060223868 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Heterocyclic amides exhibiting and inhibitory activity at the vanilloid receptor 1(vr1)' [patent_app_type] => utility [patent_app_number] => 10/554036 [patent_app_country] => US [patent_app_date] => 2004-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15823 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223868.pdf [firstpage_image] =>[orig_patent_app_number] => 10554036 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7089781 [patent_doc_number] => 20050009894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-13 [patent_title] => 'Benzimidazole derivatives and their use as KDR kinase protein inhibitors' [patent_app_type] => utility [patent_app_number] => 10/828012 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20050009894.pdf [firstpage_image] =>[orig_patent_app_number] => 10828012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467152 [patent_doc_number] => 20040198812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-07 [patent_title] => 'Pseudopolymorphic forms of carvedilol' [patent_app_type] => new [patent_app_number] => 10/827859 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6294 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0198/20040198812.pdf [firstpage_image] =>[orig_patent_app_number] => 10827859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4834162 [patent_doc_number] => 20080132709 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-05 [patent_title] => 'Dat1' [patent_app_type] => utility [patent_app_number] => 11/578566 [patent_app_country] => US [patent_app_date] => 2004-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2658 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20080132709.pdf [firstpage_image] =>[orig_patent_app_number] => 11578566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5057662 [patent_doc_number] => 20070060584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-15 [patent_title] => 'Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers' [patent_app_type] => utility [patent_app_number] => 10/553554 [patent_app_country] => US [patent_app_date] => 2004-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15628 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20070060584.pdf [firstpage_image] =>[orig_patent_app_number] => 10553554 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6952936 [patent_doc_number] => 20050228031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/823156 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17223 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228031.pdf [firstpage_image] =>[orig_patent_app_number] => 10823156 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7297648 [patent_doc_number] => 20040214875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Imidazolinylmethyl aralkylsulfonamides' [patent_app_type] => new [patent_app_number] => 10/823012 [patent_app_country] => US [patent_app_date] => 2004-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17935 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214875.pdf [firstpage_image] =>[orig_patent_app_number] => 10823012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7427876 [patent_doc_number] => 20040229927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Imidazole derivatives for treatment of allergic and hyperproliferative disorders' [patent_app_type] => new [patent_app_number] => 10/821667 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27314 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229927.pdf [firstpage_image] =>[orig_patent_app_number] => 10821667 [rel_patent_id] =>[rel_patent_doc_number] =>)